Human cytochrome P450 CYP7B1 (CYP7B1) is a 506 amino acid microsomal enzyme participating in hydroxylation of a number of steroids [1]. This protein plays crucial role in different metabolic processes: bile acids biosynthesis [2], neurosteroid metabolism [3], regulation of immunoglobulin production [4] and metabolism of estrogen receptor ligands [5]. The mRNA expression of human CYP7B1 is tissue-specific with main localization in kidneys and brain [1]. Dysfunction of CYP7B1 is associated with a number of genetic disorders such as liver failure in children and neuropathy in adults [1]. Eight different mutations in cyp7b1 gene are related with one of such neuropathies – spastic paraplegia type 5 – autosomal recessive disorder characterized by lower limb spasticity and weakness [1]. Molecular reason of this pathology still remains unclear.
Sequence analysis show that Arg486 amino acid residue is conserved in CYP7 family and located in the substrate recognition site (SRS). Examination of CYP7B1 model, build by us with CYP7A1 (PDB ID: 3DAX) as a template, showed that R486C mutation localized near the active center of the enzyme. So our hypothesis is that this mutation with changes of substrate specificity and activity of the enzyme.
In order to understand molecular background of the disorder, we constructed an expression system, expressed and purified recombinant R486C mutant of CYP7B1 (R486C). The content of native form of R486C in final preparation was more than 90%. Expression level of R486C in the same expression system as for wild type CYP7B1 (WT) was significantly lower. Good expression level was achieved only in the presence of substrate (dehydroepiandrosterone (DHEA)) in culture medium. The explanation of the fact is possible stabilization of structure by ligand binding in the enzyme active site.
Examination of ligand binding properties of R486C and comparison with the results obtained for wild type enzyme showed modified affinity of R486C for neurosteroids. $K_d$ of R486C with DHEA is two times higher than for WT. R486C did not bind pregnenolone and 21-hydroxypregnenolone. Also we found that R486C has modified affinity for different androstane derivatives.
So R486C mutation leads to substrate specificity alteration and decrease in structure stability.
Other mutant forms of CYP7B1 are under investigation. Further comparative study of normal and mutated human enzyme will help to understand the influence of enzyme mutations on the development of mentioned disorders.